3/25/2021 Grand Rounds

OEs(Ketamine): Fact, Fiction and the Navigation of Uncertainty in Neurotherapeutics

Speaker:

Robert C. Meisner, MD
Medical Director, Ketamine Service, Program in Neurotherapeutics, McLean Hospital

Learning Objectives:
    1. Describe the evolving clinical role of Ketamine and Esketamine in the treatment of Treatment Resistant Major Depressive Disorder
    2. List evidence-based indications and contra-indications for treatment, as well as to review hypothesized basic mechanisms of action
    3. Discuss common misperceptions about ketamine that are rampant as social media facilitates rapid but unchecked distributions of information